Omsättningen steg 74% sekventiellt… Mobiltelefonmarknaden i Kina fortsatte återhämta sig under kvart...
ARR kommer stärkas framöver ARR uppgick till 18,3 mkr, vilket är på samma nivå som föregående kvart...
Innofactor saw some challenges in Q2 but still reported rather decent results.
Redeye adjusts its fair value range following Hoylu’s decision to do a reverse split (1:20).
• 27% org. sales (ABGSCe 27%), 44% EBIT growth • Cons 2023e EBIT could come down 5-7% (excl.
• Sales 246m (+0% vs. ABGSC), EBITA 18m (+5% vs. ABGSC) • 15% org.
Redeye comments on Invisio’s Q2-results which came in lower than expected as deliveries was soft whi...
Redeye concludes that Q2 was considerably weaker than it expected, with product sales 68% below esti...
Consti's net sales in Q2 amounted to EUR 75.7m, roughly in line with our and consensus estimates (EU...
• Decommissioning and Scandpower excel... • ...but are overshadowed by delays within F&MT • '23e-'25...
With continued strong momentum in the networks business, we expect the traditional seasonal softness...
Atria's Q2 EBIT of EUR 10m fell short of Refinitiv consensus expectations despite continued strong t...
• Q2 in line with prior mgmt. outlook statements • Only change to ests.
• NAV ticked up 0.3%, now up 12 quarters in a row • Stock has outperformed the SIXRX YTD.
• We cut '23e-'25e adj. EBITA by 27-4% • Discontinuation of unprofitable products in full swing • '2...
• Less margin expansion than we hoped for in Q2 • EBITA down 9-7% (-3% FX), mostly from Integrated •...
Redeye states that the Q2 report was very strong with solid underlying KPIs, strong revenues from al...
Redeye comments on Evolutions Q2-results where revenue was slightly lower than our forecast while th...
A 9.2% increase in sales throughout the quarter signifies the robust nature of SSH's subscription mo...
Redeye revises its estimates on the back of the Q2 2023 report, which came in above our expectations...
